ShouTi Company

ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.


Connections from

Headquarters: South San Francisco, California, United States
Last Funding Type: Series B
Investors Number: 18.0
Last Funding Date: 2021-10-20
Employee Number: 11-50
Total Funding: 207000000.0
Founded Date: 2016-01-01
Industry: Early Drug Development
Funding Status: Early Stage Venture